ANB032 was well tolerated across all doses with no safety signals observedAD trial and all further investment in ANB032 will be discontinuedAnticipate top-line Phase 2b data in rheumatoid arthritis in ...
Due to advancements spurred by AI/ML, the impact of digital health technology will grow. Data from the Department for Promotion of Industry and Internal Trade show that FDI in the medicines and ...
Request To Download Free Sample of This Strategic Report @- In addition, rise in patient awareness toward availability of various treatments for rheumatoid arthritis, increase in focus of ...